Delivery Order SPE2DB25D2207-SPE2DB26FQPSC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,929.86 for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitively awarded, firm fixed-price contract was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,221.27 to AmerisourceBergen Drug Corp for 60-count packages of Eliquis 5 mg tablets, with an ultimate completion date of October 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $17,868.41 to AmerisourceBergen Drug Corp for 60-tablet bottles of Eliquis 5 mg, a prescription anticoagulant medication. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on June 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,977.93 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The award was made on October 27, 2025, with an ultimate completion date of October 28, 2025, under firm fixed-price terms with no set-aside designation. The contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,895.05 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract, executed on May 20, 2025, with completion by May 21, 2025, was issued under a firm fixed-price arrangement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.78 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a prescription anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $6,601.44 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $9,484.04 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-set-aside contract was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $129,776.48 to AmerisourceBergen Drug Corp for the supply of 60-tablet packages of Eliquis 5 mg tablets under a firm fixed-price contract. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB26FQPSCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,237.75 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure with an ultimate completion date of October 22, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle. The parent IDC enables the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's role as a primary pharmaceutical distributor within the DLA's medical supply chain reflects its established capability to meet federal procurement requirements for critical medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/21/25 |